CO6180437A2 - Derivados de sulfonamida como agonistas adrenergicos y antagonistas muscarinicos - Google Patents
Derivados de sulfonamida como agonistas adrenergicos y antagonistas muscarinicosInfo
- Publication number
- CO6180437A2 CO6180437A2 CO09034044A CO09034044A CO6180437A2 CO 6180437 A2 CO6180437 A2 CO 6180437A2 CO 09034044 A CO09034044 A CO 09034044A CO 09034044 A CO09034044 A CO 09034044A CO 6180437 A2 CO6180437 A2 CO 6180437A2
- Authority
- CO
- Colombia
- Prior art keywords
- sulfonamide
- derivatives
- solvate
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
en la que R1 es halo, R2 es H o halo, y Q se selecciona entre -(CH2)9- oo una sal farmacéuticamente aceptable o solvato del mismo. 2.- Un compuesto de acuerdo con la reivindicación 1, o una sal farmacéuticamente aceptable o solvato del mismo, en el que R1 es F. 3.- Un compuesto de acuerdo con la reivindicación 1, o una sal farmacéuticamente aceptable o solvato del mismo, en el que R1 es CI. 4.- Un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 3, o una sal farmacéuticamente aceptable o solvato del mismo, en el que Q es -(CH2)9-. 5.- Un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 3, o una sal farmacéuticamente aceptable o solvato del mismo, en el que Q es 6.- Un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 5, o una sal farmacéuticamente aceptable o solvato del mismo, en el que R2 es H.7.- Un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 5, o una sal farmacéuticamente aceptable o solvato del mismo, en el que R2 es F. 8.- El estereoisómero R de un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 7, o una sal farmacéuticamente aceptable o solvato del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82809906P | 2006-10-04 | 2006-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6180437A2 true CO6180437A2 (es) | 2010-07-19 |
Family
ID=38947725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09034044A CO6180437A2 (es) | 2006-10-04 | 2009-04-02 | Derivados de sulfonamida como agonistas adrenergicos y antagonistas muscarinicos |
Country Status (25)
Country | Link |
---|---|
US (1) | US20080090873A1 (es) |
EP (1) | EP2074094A1 (es) |
JP (1) | JP2010505810A (es) |
KR (1) | KR20090050104A (es) |
CN (1) | CN101522622A (es) |
AP (1) | AP2009004791A0 (es) |
AR (1) | AR063118A1 (es) |
AU (1) | AU2007303909A1 (es) |
BR (1) | BRPI0719270A2 (es) |
CA (1) | CA2665385A1 (es) |
CL (1) | CL2007002791A1 (es) |
CO (1) | CO6180437A2 (es) |
CR (1) | CR10700A (es) |
EA (1) | EA200900337A1 (es) |
IL (1) | IL197244A0 (es) |
MA (1) | MA30778B1 (es) |
MX (1) | MX2009002209A (es) |
NO (1) | NO20090910L (es) |
PE (1) | PE20080831A1 (es) |
RS (1) | RS20090137A (es) |
TN (1) | TN2009000112A1 (es) |
TW (1) | TW200823185A (es) |
UY (1) | UY30617A1 (es) |
WO (1) | WO2008041095A1 (es) |
ZA (1) | ZA200901320B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドPfizer Limited | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
ITRM20110083U1 (it) | 2010-05-13 | 2011-11-14 | De La Cruz Jose Antonio Freire | Piastra per la costruzione di carrelli per aeroplani |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
MA38260B1 (fr) | 2012-12-18 | 2018-04-30 | Almirall Sa | Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3 |
TWI643853B (zh) | 2013-02-27 | 2018-12-11 | 阿爾米雷爾有限公司 | 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類 |
TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有maba化合物和皮質類固醇之組合 |
TWI641373B (zh) | 2013-07-25 | 2018-11-21 | 阿爾米雷爾有限公司 | 具有蕈毒鹼受體拮抗劑和β2腎上腺素受體促效劑二者之活性的2-胺基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽 |
TW201617343A (zh) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β2腎上腺素促效劑及M3蕈毒拮抗劑活性之新穎雙環衍生物 |
CN106336406B (zh) * | 2015-07-10 | 2020-01-03 | 四川海思科制药有限公司 | 具有β2受体激动及M受体拮抗活性的八氢并环戊二烯衍生物及其在医药上的用途 |
CN110087729B (zh) | 2016-12-14 | 2022-04-05 | 北京硕佰医药科技有限责任公司 | 一类具有季铵盐结构的双功能化合物 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CN114748622A (zh) | 2017-10-05 | 2022-07-15 | 弗尔康医疗公司 | P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd |
EP3720852A1 (en) * | 2017-12-04 | 2020-10-14 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Fluorophenyl substituted muscarinic receptor ligands with selectivity for m3 over m2 |
AU2021296221A1 (en) | 2020-06-26 | 2023-02-02 | Mylan Pharma Uk Limited | Formulations including 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
JP4767842B2 (ja) * | 2003-04-01 | 2011-09-07 | セラヴァンス, インコーポレーテッド | β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
ES2329133T3 (es) * | 2003-05-28 | 2009-11-23 | Theravance, Inc. | Compuestos azabicicloalcanicos como antagonistas de receptores de muscarinicos. |
PT1708992E (pt) * | 2004-01-22 | 2007-11-16 | Pfizer | Derivados de sulfonamida para o tratamento de doenças |
US7320990B2 (en) * | 2004-02-13 | 2008-01-22 | Theravance, Inc. | Crystalline form of a biphenyl compound |
TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
-
2007
- 2007-09-21 AU AU2007303909A patent/AU2007303909A1/en not_active Abandoned
- 2007-09-21 KR KR1020097006899A patent/KR20090050104A/ko not_active Application Discontinuation
- 2007-09-21 EA EA200900337A patent/EA200900337A1/ru unknown
- 2007-09-21 WO PCT/IB2007/002896 patent/WO2008041095A1/en active Application Filing
- 2007-09-21 AP AP2009004791A patent/AP2009004791A0/xx unknown
- 2007-09-21 BR BRPI0719270-3A patent/BRPI0719270A2/pt not_active IP Right Cessation
- 2007-09-21 CN CNA2007800373310A patent/CN101522622A/zh active Pending
- 2007-09-21 MX MX2009002209A patent/MX2009002209A/es not_active Application Discontinuation
- 2007-09-21 CA CA002665385A patent/CA2665385A1/en not_active Abandoned
- 2007-09-21 JP JP2009530960A patent/JP2010505810A/ja not_active Withdrawn
- 2007-09-21 RS RSP-2009/0137A patent/RS20090137A/sr unknown
- 2007-09-21 EP EP07805009A patent/EP2074094A1/en not_active Withdrawn
- 2007-09-27 CL CL200702791A patent/CL2007002791A1/es unknown
- 2007-09-27 PE PE2007001318A patent/PE20080831A1/es not_active Application Discontinuation
- 2007-10-02 US US11/906,796 patent/US20080090873A1/en not_active Abandoned
- 2007-10-02 UY UY30617A patent/UY30617A1/es not_active Application Discontinuation
- 2007-10-03 TW TW096137048A patent/TW200823185A/zh unknown
- 2007-10-03 AR ARP070104386A patent/AR063118A1/es not_active Application Discontinuation
-
2009
- 2009-02-24 ZA ZA200901320A patent/ZA200901320B/xx unknown
- 2009-02-25 IL IL197244A patent/IL197244A0/en unknown
- 2009-02-26 NO NO20090910A patent/NO20090910L/no not_active Application Discontinuation
- 2009-03-31 CR CR10700A patent/CR10700A/es not_active Application Discontinuation
- 2009-03-31 TN TN2009000112A patent/TN2009000112A1/fr unknown
- 2009-04-02 CO CO09034044A patent/CO6180437A2/es not_active Application Discontinuation
- 2009-04-03 MA MA31760A patent/MA30778B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AR063118A1 (es) | 2008-12-30 |
IL197244A0 (en) | 2009-12-24 |
CL2007002791A1 (es) | 2008-04-11 |
CN101522622A (zh) | 2009-09-02 |
EP2074094A1 (en) | 2009-07-01 |
TW200823185A (en) | 2008-06-01 |
JP2010505810A (ja) | 2010-02-25 |
WO2008041095A1 (en) | 2008-04-10 |
TN2009000112A1 (fr) | 2010-08-19 |
NO20090910L (no) | 2009-03-24 |
MA30778B1 (fr) | 2009-10-01 |
BRPI0719270A2 (pt) | 2014-03-11 |
PE20080831A1 (es) | 2008-06-20 |
US20080090873A1 (en) | 2008-04-17 |
CR10700A (es) | 2009-04-24 |
RS20090137A (en) | 2010-06-30 |
AU2007303909A1 (en) | 2008-04-10 |
ZA200901320B (en) | 2010-04-28 |
KR20090050104A (ko) | 2009-05-19 |
MX2009002209A (es) | 2009-03-16 |
UY30617A1 (es) | 2008-05-31 |
EA200900337A1 (ru) | 2009-10-30 |
CA2665385A1 (en) | 2008-04-10 |
AP2009004791A0 (en) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6180437A2 (es) | Derivados de sulfonamida como agonistas adrenergicos y antagonistas muscarinicos | |
AR055570A1 (es) | Polimorfo de oxazol - pirrolidina, procesos de obtencion y composiciones farmaceuticas. | |
ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
PE20060937A1 (es) | Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2) | |
ECSP088627A (es) | Compuestos para el tratamiento de trastornos inflamatorios | |
PE20211700A1 (es) | Compuesto heterociclico y su uso | |
PE20091317A1 (es) | Antagonista del receptor opioide selectivo kappa | |
AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
CO6140054A2 (es) | Compuestos de dialquilfenilo con actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarinico | |
GT200600294A (es) | Mezclas fungicidas a base de bifenilamidas de ácido pirazolcarboxílico 3-monosustituidas | |
CR20120524A (es) | Combinaciones que contienen 2,3-dihidroimidazo [1,2-c] quinazolina sustituida | |
CO6361993A2 (es) | Compuestos de 4-[2-(2-fluorofenoximetil)fenil]piperidina | |
BRPI0606639A2 (pt) | novo processo para a preparação de indóis substituìdos | |
CL2017002960A1 (es) | Compuesto para la profilaxis o el tratamiento de daño al órgano | |
AR076362A1 (es) | Arilsulfonamidas 2,5-disustituidas antagonistas de ccr3, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento y/o prevencion de patologias autoinmunes e inflamatorias, entre otras. | |
UY32414A (es) | Nuevos metodos | |
DOP2006000030A (es) | Nueva forma de sal de un agonista de dopamina | |
AR057526A1 (es) | Metodos para la produccion de composiciones oftalmicas oxidativamente estables | |
PE20060942A1 (es) | Derivados nonadepsipeptidos acilados ii como agentes bactericidas | |
CL2008003332A1 (es) | Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma. | |
AR057935A1 (es) | Combinacion de productos activos fungicidas | |
RU2011103476A (ru) | Нифуртимокс для лечения болезней, вызванных трихомонадидами | |
UY31548A1 (es) | Derivados de azetidinas, su preparacion y su aplicacion en terapéutica | |
CR8314A (es) | Mezclas fungicidas para combatir patogenos del arroz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |